MUM1 and BCL6 but not HGAL are independent prognostic indicators of outcome in nodal diffuse large B-Cell lymphoma

被引：0
|
作者：
Wongchaowart, NT
Segota, E
Pohlman, B
Lossos, IS
Natkunam, Y
Levy, R
Jin, T
Hsi, ED
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] Univ Miami, Miami, FL 33152 USA
[3] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1167
引用
收藏
页码：252A / 252A
页数：1
相关论文
共 50 条
  • [1] MUM1 and BCL6 but not HGAL are independent prognostic indicators of outcome in nodal diffuse large B-cell lymphoma
    Wongchaowart, NT
    Segota, E
    Pohlman, B
    Lossos, IS
    Natkunam, Y
    Levy, R
    Jin, T
    Hsi, ED
    MODERN PATHOLOGY, 2006, 19 : 252A - 252A
  • [2] Immunohistochemical expression of CD10, BCL6, and MUM1 in primary nodal diffuse large B-cell lymphoma: MUM1 expression alone (but not germinal center B-cell immunophenotype) is an independent prognostic factor.
    Wongchaowart, N
    Segota, E
    Jin, T
    Pohlman, B
    Hsi, ED
    BLOOD, 2005, 106 (11) : 257B - 257B
  • [3] CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples
    Cozzolino, Immacolata
    Varone, Valeria
    Picardi, Marco
    Baldi, Carlo
    Memoli, Domenico
    Ciancia, Giuseppe
    Selleri, Carmine
    De Rosa, Gaetano
    Vetrani, Antonio
    Zeppa, Pio
    CANCER CYTOPATHOLOGY, 2016, 124 (02) : 135 - 143
  • [4] The distinct clinical features and prognosis of the CD10+MUM1+ and CD10−Bcl6−MUM1− diffuse large B-cell lymphoma
    Ting-Xun Lu
    Yi Miao
    Jia-Zhu Wu
    Qi-Xing Gong
    Jin-Hua Liang
    Zhen Wang
    Li Wang
    Lei Fan
    Dong Hua
    Yao-Yu Chen
    Wei Xu
    Zhi-Hong Zhang
    Jian-Yong Li
    Scientific Reports, 6
  • [5] Immunohistochemical Expression of CD10, BCL6 and MUM1 in Differentiating Diffuse Large B Cell Lymphoma Subtypes
    Bajwa, Akhter Ali
    Khadim, Muhammad Tahir
    Din, Hafeez Ud
    Ali, Syed Salman
    Jamil, Unaiza
    Khan, Umair Aslam Shahzad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2017, 27 (10): : 621 - 624
  • [6] PROGNOSTIC IMPACT OF BCL6 GENE REARRANGEMENT IN DIFFUSE LARGE B-CELL LYMPHOMA
    Chekan, A.
    Tumyan, G.
    Kovrigina, A.
    Bykov, D.
    Zeinalova, P.
    Kichigina, M.
    Kolomeytsev, O.
    Osmanov, D.
    Lepkov, S.
    HAEMATOLOGICA, 2012, 97 : 650 - 650
  • [7] Response: BCL6 and outcome in diffuse large B-cell lymphoma: a work in progress
    Moskowitz, Craig H.
    Hamlin, Paul A.
    Zelenetz, Andrew D.
    BLOOD, 2007, 109 (02) : 845 - 845
  • [8] Translocations Involving MUM1 are Rare in Diffuse Large B-cell Lymphoma
    Hunt, Kristin E.
    Hall, Bryan
    Reichard, Kaaren K.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2010, 18 (02) : 109 - 112
  • [9] Association of AID and MUM1 by Immunohistochemistry in Diffuse Large B-Cell Lymphoma
    Hardianti, Mardiah Suci
    Setiawan, Syahru Agung
    Anggorowati, Nungki
    Probowati, Wiwiek
    INDONESIAN BIOMEDICAL JOURNAL, 2021, 13 (01): : 48 - 54
  • [10] Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma
    Barrans, SL
    O'Connor, SJM
    Evans, PAS
    Davies, FE
    Owen, RG
    Haynes, AP
    Morgan, GJ
    Jack, AS
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (02) : 322 - 332
12345